BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 7697445)

  • 1. Complement activation and immune complexes in early congenital HIV infection.
    Jarvis JN; Taylor H; Iobidze M
    J Acquir Immune Defic Syndr Hum Retrovirol; 1995 Apr; 8(5):480-5. PubMed ID: 7697445
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A comparison of immunoglobulin G-containing high-molecular-weight complexes isolated from children with juvenile rheumatoid arthritis and congenital human immunodeficiency virus infection.
    Jarvis JN; Iobidze M; Taylor H; DeJonge J; Chang S
    Pediatr Res; 1993 Dec; 34(6):781-4. PubMed ID: 8108193
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activation of the complement system in human immunodeficiency virus infection: relevance of the classical pathway to pathogenesis and disease severity.
    Senaldi G; Peakman M; McManus T; Davies ET; Tee DE; Vergani D
    J Infect Dis; 1990 Dec; 162(6):1227-32. PubMed ID: 1977807
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Decreased levels of complement receptor 1 (CD35) on B lymphocytes in persons with HIV infection.
    Munson LG; Scott ME; Landay AL; Spear GT
    Clin Immunol Immunopathol; 1995 Apr; 75(1):20-5. PubMed ID: 7533682
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Significance of complement components C1q and C4 bound to circulating immune complexes in juvenile idiopathic arthritis: support for classical complement pathway activation.
    Gilliam BE; Reed MR; Chauhan AK; Dehlendorf AB; Moore TL
    Clin Exp Rheumatol; 2011; 29(6):1049-56. PubMed ID: 22153664
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rheumatoid factor expression and complement activation in children congenitally infected with human immunodeficiency virus.
    Jarvis JN; Taylor H; Iobidze M; Dejonge J; Chang S; Cohen F
    Clin Immunol Immunopathol; 1993 Apr; 67(1):50-4. PubMed ID: 8443984
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reflection of disease activity in rheumatoid arthritis by indices of activation of the classical complement pathway.
    Makinde VA; Senaldi G; Jawad AS; Berry H; Vergani D
    Ann Rheum Dis; 1989 Apr; 48(4):302-6. PubMed ID: 2785367
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Complement activation and immune complexes in juvenile rheumatoid arthritis.
    Jarvis JN; Pousak T; Krenz M; Iobidze M; Taylor H
    J Rheumatol; 1993 Jan; 20(1):114-7. PubMed ID: 8441140
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immune complex mediated activation of the classical complement pathway.
    Borsos T
    Behring Inst Mitt; 1989 Jul; (84):93-101. PubMed ID: 2478118
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Complexes between C1q and C3 or C4: novel and specific markers for classical complement pathway activation.
    Wouters D; Wiessenberg HD; Hart M; Bruins P; Voskuyl A; Daha MR; Hack CE
    J Immunol Methods; 2005 Mar; 298(1-2):35-45. PubMed ID: 15847795
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunoglobulin and complement complexes in blood following infection with human immunodeficiency virus type 1.
    Peng XX; Wainberg MA; Tao Y; Brenner BG
    Clin Diagn Lab Immunol; 1996 Jan; 3(1):128-31. PubMed ID: 8770516
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HIV and complement: role of the complement system in HIV infection.
    Marschang P; Ebenbichler CF; Dierich MP
    Int Arch Allergy Immunol; 1994; 103(2):113-7. PubMed ID: 8292898
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rat polymeric IgA binds C1q, but does not activate C1.
    Hiemstra PS; Rits M; Gorter A; Stuurman ME; Hoekzema R; Bazin H; Vaerman JP; van Es LA; Daha MR
    Mol Immunol; 1990 Sep; 27(9):867-74. PubMed ID: 2215479
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Elevated levels of iC3b and C4d, but not Bb, complement fragments from plasma of persons infected with human T cell leukemia virus (HTLV) with HTLV-I-associated myelopathy/tropical spastic paraparesis.
    Saarloos MN; Koenig RE; Spear GT
    J Infect Dis; 1995 Oct; 172(4):1095-7. PubMed ID: 7561187
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The complement system in HIV disease.
    Füst G; Ujhelyi E; Hidvégi T; Pálóczi K; Mihalik R; Hollán S; Nagy K; Kirschfink M
    Immunol Invest; 1991 Apr; 20(2):231-41. PubMed ID: 1864641
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of classical complement pathway activation in rheumatoid arthritis: measurement of C1q-C4 complexes as novel activation products.
    Wouters D; Voskuyl AE; Molenaar ET; Dijkmans BA; Hack CE
    Arthritis Rheum; 2006 Apr; 54(4):1143-50. PubMed ID: 16572449
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Complement-Mediated Neutralization of a Potent Neurotropic Human Pathogen, Chandipura Virus, Is Dependent on C1q.
    Kunnakkadan U; Nag J; Kumar NA; Mukesh RK; Suma SM; Johnson JB
    J Virol; 2019 Oct; 93(19):. PubMed ID: 31315998
    [TBL] [Abstract][Full Text] [Related]  

  • 18. C1q and C4b bind simultaneously to CR1 and additively support erythrocyte adhesion.
    Tas SW; Klickstein LB; Barbashov SF; Nicholson-Weller A
    J Immunol; 1999 Nov; 163(9):5056-63. PubMed ID: 10528211
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activation of the classical complement pathway in brain tissue of Alzheimer patients.
    McGeer PL; Akiyama H; Itagaki S; McGeer EG
    Neurosci Lett; 1989 Dec; 107(1-3):341-6. PubMed ID: 2559373
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The classical and regulatory functions of C1q in immunity and autoimmunity.
    Lu JH; Teh BK; Wang Ld; Wang YN; Tan YS; Lai MC; Reid KB
    Cell Mol Immunol; 2008 Feb; 5(1):9-21. PubMed ID: 18318990
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.